Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
China
Industries Focus
- Technology
- Healthcare
- Energy
- Consumer Goods
- Business Services
- Manufacturing
- Clean Tech
Investor Details Founded: 2012
Grand Yangtze Capital is a Shanghai-based private equity firm specializing in early-stage investments across sectors such as consumer goods, clean tech, business services, energy, technology, healthcare, and manufacturing within China. The firm manages both private equity and venture capital funds, focusing on growth and expansion-stage enterprises.
The firm's investment strategy encompasses a broad range of industries, including consumer goods, clean tech, business services, energy, technology, healthcare, and manufacturing. They target early-stage, growth, and late-stage companies, aiming to support their development and expansion within China.
Grand Yangtze Capital has a track record of over 40 investments, with several companies achieving public listings or undergoing mergers and acquisitions. Their portfolio includes notable companies such as Sino-Crystal, Shuanghuan, Hainan Rubber, HLBN, ZMJ, China UMS, ZBT Pharma, ELLASSAY, B-Soft, Guochuang Software, YMatou, Pharma Block, and others. This demonstrates their active role in fostering the growth of diverse enterprises across multiple sectors in China.
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Sino-Crystal
- Shuanghuan
- Hainan Rubber
- HLBN
- ZMJ
- China UMS
- ZBT Pharma
- ELLASSAY
- B-Soft
- Guochuang Software
- Ymatou
- Pharma Block
Mentioned In
-
$19.95
-
$9.95
-
$29.95
-
$39.95
Claim this Investor
Are you an official representative of Grand Yangtze Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim